Αποτελέσματα Αναζήτησης
We aimed to assess the effects of cannabis on the onset and course of depression, bipolar disorder, anxiety disorders, and post-traumatic stress disorder (PTSD), and also to explore the therapeutic potential of cannabis and cannabinoids for these disorders.
- Table 3
Diagnosis N Design Intervention Comparator Outcome...
- A Test of The Psychosocial Failure Model
The logit link function was used, as appropriate with binary...
- Cannabis Use and Depression
Among the 45 087 subjects, a total of 1 146 individuals had...
- Table 3
After statistical control for marijuana use frequency age of marijuana use onset, as well as sociodemographic characteristics and other substance use, depression was positively and significantly associated with each of the marijuana use disorder symptoms and with a greater number of symptoms.
8 Απρ 2024 · By considering various dimensions, such as depressive and manic symptoms, diagnostic outcomes, cognition, neuroimaging and treatment outcomes, this review provides multifaceted assessment of the impact of cannabis use on mood disorders.
While a slight majority of medical marijuana users report using marijuana for depression and generally find it helpful, some evidence suggests that reductions in marijuana use by those with depression may actually reduce depressive symptoms. Introduction. Marijuana is the most commonly used drug of abuse in the United States. 1
14 Μαΐ 2021 · The prevalence of depressive disorders is high in cannabis users (25%). Risk factors include female gender and earlier age of onset of use (51). The prevalence of major depressive disorder (MDD) in those with cannabis dependence (CD), CUD, and cannabis abuse (CA) is ~6.9, 4.7, and 1.0%, respectively (52).
Cannabis use, and particularly heavy cannabis use, may be associated with an increased risk for developing depressive disorders. There is need for further longitudinal exploration of the association between cannabis use and developing depression, particularly taking into account cumulative exposure to cannabis and potentially significant ...
3 Φεβ 2021 · Clinical evaluation and 15-item mood checklist (scores not reported) revealed no improvement in depressive symptoms. A 50% attrition rate was reported because of sedation, anxiety, and depersonalization, even after a single dose.
